Home / Sweden / Vicore Pharma Holding AB
Vicore Pharma Holding AB
SE0007577895 Short position disclosed on July 31, 2026.
0.70% of the capital sold short
1 disclosing funds
9 disclosures on record
Funds holding Vicore Pharma Holding AB Titelia
Evolution of the disclosed total
0%0.2%0.4%0.6%0.8%
Oct 2025Jan 2026Apr 2026Jul 2026
October 1, 2024 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Qube Research & Technologies Limited | 0.70% | new | July 31, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| July 31, 2026 | Qube Research & Technologies Limited | 0.70% | still open |
| July 10, 2026 | Qube Research & Technologies Limited | 0.61% | still open |
| July 9, 2026 | Qube Research & Technologies Limited | 0.59% | still open |
| July 8, 2026 | Qube Research & Technologies Limited | 0.60% | still open |
| July 7, 2026 | Qube Research & Technologies Limited | 0.59% | still open |
| June 11, 2026 | Qube Research & Technologies Limited | 0.70% | still open |
| June 4, 2026 | Qube Research & Technologies Limited | 0.61% | still open |
| June 1, 2026 | Qube Research & Technologies Limited | 0.50% | still open |
| October 1, 2024 | Jane Street Group LLC | 0.66% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.30% of the capital sold short
- Elekta AB (publ) 10.32% of the capital sold short
- JM AB 7.01% of the capital sold short
- Embracer Group AB 5.83% of the capital sold short
- Hemnet Group AB (publ) 5.59% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Bonesupport Holding AB 5.38% of the capital sold short
- Xvivo Perfusion Aktiebolag 5.02% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- Stillfront Group AB (publ) 3.87% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
- RaySearch Laboratories AB (publ) 3.63% of the capital sold short